The Global Initiative for Chronic Obstructive Lung Disease (GOLD) published its first report
for the diagnosis and management of chronic obstructive pulmonary disease (COPD) in …

The role of the blood eosinophil count as a biomarker predictor of the frequency of
exacerbations and response to corticosteroid treatment in chronic obstructive pulmonary …

Chronic obstructive pulmonary disease (COPD) is a complex condition with pathophysiology
and clinical characteristics that vary in presence and severity between patients (1). This …

The impact of blood eosinophilia in chronic obstructive pulmonary disease (COPD) remains
controversial. To evaluate the prevalence and stability of a high level of blood eosinophils …

Rationale: Whether high blood eosinophils are associated with chronic obstructive
pulmonary disease (COPD) exacerbations among individuals with COPD in the general …

In recent years, heterogeneity in chronic obstructive pulmonary disease (COPD)
inflammatory patterns has been recognized as a basis for more precise treatment …

Background Eosinophilic airway inflammation characterizes a chronic obstructive pulmonary
disease (COPD) phenotype that requires more study. Objective To investigate the …

Background Blood eosinophils have been suggested as a potential biomarker in chronic
obstructive pulmonary disease (COPD), and their stability over time has been investigated in …

Background Inhaled corticosteroids are important in the management of chronic obstructive
pulmonary disease (COPD), but can slightly increase the risk of pneumonia in patients with …

COPD is a significant cause of morbidity and mortality. In some patients with COPD,
eosinophils contribute to inflammation that promotes airway obstruction; approximately a …